Share facts

Explore basic facts about Metso's share.

  2009 2010 2011 2012 2013 2014* 2015
Dividend/share, EUR
0.70
1.55
1.70
1.85
1.00
1.05
1.05
Dividend, EUR million
105
232
254
277
150
 157 157
Dividend/earnings, %
66
91
71
74
63
 84 36
Effective dividend yield, %
2.8
3.7
5.9
5.8
3.2
 4.2 5.1

*An extra dividend of EUR 0.40 was paid in August 2015

December 31, 2015
 2012201320142015
Share capital, EUR million 241 141 141 141
Shares outstanding 150,348,256 150,348,256 150,348,256 150,348,256
Own shares held 592,222 483,637  458,988 363,718
Trading volume on the Helsinki Exchange 223,439,548 173,318,027  170,218,971 150,739,847
                     - percentage of total amount of shares 149 116 114 101

 

Metso's share capital at the end of 2015 was EUR 140,982,843.80 and the number of shares was 150,348,256 shares. Metso has one class of shares. Each share entitles its holder to one vote at the Annual General Meeting and to an equal amount of dividend.

The 2015 Annual General Meeting approved on March 21, 2016 the proposals of the Board to authorize the Board to decide on the repurchase of the company’s own shares.

Authorizing the Board of Directors to decide on the repurchase of the company’s own shares

The amount of own shares to be repurchased shall not exceed 10,000,000 shares, which corresponds to approximately 6.7 percent of all the shares in the Company. Own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders (directed repurchase). Own shares can be repurchased using the unrestricted equity of the Company at a price formed in public trading on the date of the repurchase or otherwise at a price determined by the markets. 
Own shares may be repurchased in order to develop the Company’s capital structure, in order to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares as part of the Company’s incentive scheme.

The repurchased shares may be held for reissue, canceled or transferred further.

The Board of Directors decides on all other matters related to the repurchase of own shares.
The authorization is effective until June 30, 2017 and it cancels the authorization given to the Board of Directors by the Annual General Meeting on March 27, 2015 to decide on the repurchase of the Company’s own shares.

 

Authorizing the Board of Directors to decide on the issuance of shares and special rights entitling to shares

The Board of Directors is furthermore authorized to issue special rights referred to in Chapter 10 Section 1 of the Companies Act entitling their holder to receive new shares or the Company’s own shares for consideration in such a manner that the subscription price of the shares is to be set off against a receivable of the subscriber (“Convertible Bond”). The amount of shares which may be issued or transferred based on the special rights shall not exceed 15,000,000 shares, which corresponds to approximately 10 percent of all shares in the Company. This aggregate number of shares is included in the aggregate numbers of shares that may be issued and/or transferred mentioned in the previous paragraph.

The new shares may be issued and the Company’s own shares may be transferred for consideration or without consideration.

The Board of Directors is also authorized to decide on a share issue to the Company itself without consideration. The amount of shares which may be issued to the Company, together with the amount of shares to be repurchased based on the authorization, shall not exceed 10,000,000 shares, which corresponds to approximately 6.7 percent of all shares in the Company.

The new shares and the special rights referred to in Chapter 10 Section 1 of the Companies Act may be issued and the Company’s own shares transferred to the shareholders in proportion to their current shareholdings in the Company. The new shares and the special rights referred to in Chapter 10 Section 1 of the Companies Act may also be issued and the Company’s own shares transferred in deviation from the shareholders' pre-emptive rights by way of a directed issue if there is a weighty financial reason for the Company to do so. The deviation from the shareholders' pre-emptive rights may be carried out for example in order to develop the Company’s capital structure, in order to finance or carry out acquisitions, investments or other business transactions, or in order to use the shares for an incentive scheme. A directed share issue may be executed without consideration only if there is an especially weighty financial reason for the Company to do so, taking the interests of all its shareholders into account.